Fujifilm scales New Jersey operations as ELUXEO and therapeutic scope adoption grows
See why Fujifilm’s new endoscopy warehouse could strengthen service capacity, device uptime and U.S. hospital growth. Read the full analysis.
See why Fujifilm’s new endoscopy warehouse could strengthen service capacity, device uptime and U.S. hospital growth. Read the full analysis.
AbbVie reports positive Phase 3 AFFIRM trial results for risankizumab subcutaneous induction in Crohn’s disease. Discover what the findings mean for treatment.
Biomerica reports real-world IBS responder data and Medicare coverage. Explore what this means for adoption, reimbursement, and competition.
Bausch’s RED-C trial failed to meet endpoints in hepatic encephalopathy prevention. Find out what this means for rifaximin SSD’s future and the field.